Skip to content

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2017

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2017

The information is for S. enterica culture isolates received during the designated year.

Serotypic name No. tested Sterile site specimens Non-sterile site specimens
Total Not susceptible % Total Not susceptible %
Ciprofloxacin Ceftriaxone Ciprofloxacin Ceftriaxone
Enteritidis 770 172 69.8% 6.4% 598 67.4% 2.3%
I 4:i:- 411 10 70.0% 30.0% 401 34.4% 11.5%
Typhimurium 197 14 50.0% 7.1% 183 68.3% 2.2%
Rissen 118 3 33.3% 0.0% 115 12.2% 0.0%
London 91 4 50.0% 0.0% 87 52.9% 2.3%
Derby 78 1 100.0% 0.0% 77 55.8% 1.3%
Stanley 71 0 - - 71 11.3% 2.8%
Weltevreden 35 1 0.0% 0.0% 34 5.9% 0.0%
Goldcoast 31 3 100.0% 0.0% 28 64.3% 3.6%
Paratyphi B, variant Java 22 4 0.0% 0.0% 18 0.0% 0.0%
Saintpaul 20 3 100.0% 0.0% 17 82.4% 0.0%
Bareilly 18 2 100.0% 0.0% 16 62.5% 0.0%
Newport 14 0 - - 14 42.9% 0.0%
Kentucky 13 1 100.0% 100.0% 12 83.3% 58.3%
Typhi 12 12 58.3% 0.0% 0 - -
Virchow 11 2 100.0% 0.0% 9 66.7% 0.0%
Singapore 11 0 - - 11 72.7% 0.0%
Infantis 11 0 - - 11 63.6% 0.0%
I 8,20:z4,z23:- 10 0 - - 10 90.0% 0.0%
Wandsworth 9 0 - - 9 66.7% 0.0%
Others 141 8 37.5% 0.0% 133 39.1% 3.0%


Remark:

Multiple strains may have been received from the same patient.